Larisa V Mochalova

Title: Larisa V Mochalova: Innovator in Viral Attachment Inhibition

Introduction

Larisa V Mochalova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of virology, particularly in the development of novel compounds that inhibit viral attachment to target cells. Her innovative work has the potential to impact therapeutic strategies against viral infections.

Latest Patents

Larisa V Mochalova holds a patent for "Viral attachment inhibitors." This patent describes the use of novel neuraminic acid compounds that inhibit viral attachment to target cells. The compounds are characterized by specific chemical formulas, where R.sup.1 can be hydrogen or acetyl, R.sup.2 can be hydrogen or methyl, and Y is selected from a defined group. These compounds effectively bind to virus particles and are resistant to cleavage by neuraminidase, enhancing their efficacy. Additionally, coupling these compounds to a polymer further inhibits viral attachment.

Career Highlights

Throughout her career, Larisa has focused on innovative solutions in virology. Her research has led to advancements in understanding how viruses interact with host cells, paving the way for new therapeutic approaches. Her dedication to scientific inquiry and innovation has established her as a respected figure in her field.

Collaborations

Larisa has collaborated with notable colleagues, including Nicolai Vladimirovich Bovin and Nargiz E Bryamova. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in viral research.

Conclusion

Larisa V Mochalova's contributions to the field of virology through her patent on viral attachment inhibitors exemplify her commitment to scientific advancement. Her work not only showcases her innovative spirit but also holds promise for future therapeutic developments.